CD4 and infection: We introduced MPA after exposure of the CD4+ T cells to HIV, to ensure that differential activation of CD4+ T cells was not a confounding factor, whereas Sampah and Huijbregts treated CD4+ T cells with MPA prior to infection with HIV.